ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Rani Therapeutics LLC

Official 2024 U.S. DOL Form 5500 summary for Rani Therapeutics LLC (Rani Therapeutics 401(k) Plan · EIN 61-1677171 · PN 001): $7.41M net assets, 106 active participants, and $13.40 per $10,000 (13.40 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorRani Therapeutics LLC
Filing IdentifierRani Therapeutics 401(k) Plan · EIN 61-1677171 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$7.41M
Active Participants106
Direct Admin Fee Rate$13.40 per $10,000 (13.40 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderMorgan Stanley
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($1,884, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI